101 research outputs found
The complex genetics of multiple sclerosis: pitfalls and prospects
The genetics of complex disease is entering a new and exciting era. The exponentially growing knowledge and technological capabilities emerging from the human genome project have finally reached the point where relevant genes can be readily and affordably identified. As a result, the last 12 months has seen a virtual explosion in new knowledge with reports of unequivocal association to relevant genes appearing almost weekly. The impact of these new discoveries in Neuroscience is incalculable at this stage but potentially revolutionary. In this review, an attempt is made to illuminate some of the mysteries surrounding complex genetics. Although focused almost exclusively on multiple sclerosis all the points made are essentially generic and apply equally well, with relatively minor addendums, to any other complex trait, neurological or otherwise
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder : differential involvement of immune-related gene loci
J. Saarela työryhmäjäsen.Peer reviewe
Genetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset
<p>Abstract</p> <p>Background</p> <p>When selecting mates, many vertebrate species seek partners with major histocompatibility complex (MHC) genes different from their own, presumably in response to selective pressure against inbreeding and towards MHC diversity. Attempts at replication of these genetic results in human studies, however, have reached conflicting conclusions.</p> <p>Results</p> <p>Using a multi-analytical strategy, we report validated genome-wide relationships between genetic identity and human mate choice in 930 couples of European ancestry. We found significant similarity between spouses in the MHC at class I region in chromosome 6p21, and at the odorant receptor family 13 locus in chromosome 9. Conversely, there was significant dissimilarity in the MHC class II region, near the <it>HLA-DQA1 </it>and -<it>DQB1 </it>genes. We also found that genomic regions with significant similarity between spouses show excessive homozygosity in the general population (assessed in the HapMap CEU dataset). Conversely, loci that were significantly dissimilar among spouses were more likely to show excessive heterozygosity in the general population.</p> <p>Conclusions</p> <p>This study highlights complex patterns of genomic identity among partners in unrelated couples, consistent with a multi-faceted role for genetic factors in mate choice behavior in human populations.</p
The novel endosomal membrane protein Ema interacts with the class C Vps–HOPS complex to promote endosomal maturation
Defective attenuation of BMP signaling causes synapses to overgrow in Drosophila Ema mutants due to impaired endosomal maturation
A comparison of genomic profiles of complex diseases under different models
Background: Various approaches are being used to predict individual risk to polygenic diseases from data provided
by genome-wide association studies. As there are substantial differences between the diseases investigated, the data
sets used and the way they are tested, it is difficult to assess which models are more suitable for this task.
Results: We compared different approaches for seven complex diseases provided by the Wellcome Trust Case
Control Consortium (WTCCC) under a within-study validation approach. Risk models were inferred using a variety of
learning machines and assumptions about the underlying genetic model, including a haplotype-based approach with
different haplotype lengths and different thresholds in association levels to choose loci as part of the predictive
model. In accordance with previous work, our results generally showed low accuracy considering disease heritability
and population prevalence. However, the boosting algorithm returned a predictive area under the ROC curve (AUC)
of 0.8805 for Type 1 diabetes (T1D) and 0.8087 for rheumatoid arthritis, both clearly over the AUC obtained by other
approaches and over 0.75, which is the minimum required for a disease to be successfully tested on a sample at risk,
which means that boosting is a promising approach. Its good performance seems to be related to its robustness to
redundant data, as in the case of genome-wide data sets due to linkage disequilibrium.
Conclusions: In view of our results, the boosting approach may be suitable for modeling individual predisposition to
Type 1 diabetes and rheumatoid arthritis based on genome-wide data and should be considered for more in-depth
research.This work was supported by the Spanish Secretary of Research, Development
and Innovation [TIN2010-20900-C04-1]; the Spanish Health Institute Carlos III
[PI13/02714]and [PI13/01527] and the Andalusian Research Program under
project P08-TIC-03717 with the help of the European Regional Development
Fund (ERDF). The authors are very grateful to the reviewers, as they believe that
their comments have helped to substantially improve the quality of the paper
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis
<p>Abstract</p> <p>Background</p> <p>Multiple sclerosis (MS) is a complex disorder thought to result from an interaction between environmental and genetic predisposing factors which have not yet been characterised, although it is known to be associated with the HLA region on 6p21.32. Recently, a picture of chronic cerebrospinal venous insufficiency (CCSVI), consequent to stenosing venous malformation of the main extra-cranial outflow routes (VM), has been described in patients affected with MS, introducing an additional phenotype with possible pathogenic significance.</p> <p>Methods</p> <p>In order to explore the presence of copy number variations (CNVs) within the HLA locus, a custom CGH array was designed to cover 7 Mb of the HLA locus region (6,899,999 bp; chr6:29,900,001-36,800,000). Genomic DNA of the 15 patients with CCSVI/VM and MS was hybridised in duplicate.</p> <p>Results</p> <p>In total, 322 CNVs, of which 225 were extragenic and 97 intragenic, were identified in 15 patients. 234 known polymorphic CNVs were detected, the majority of these being situated in non-coding or extragenic regions. The overall number of CNVs (both extra- and intragenic) showed a robust and significant correlation with the number of stenosing VMs (Spearman: r = 0.6590, p = 0.0104; linear regression analysis r = 0.6577, p = 0.0106).</p> <p>The region we analysed contains 211 known genes. By using pathway analysis focused on angiogenesis and venous development, MS, and immunity, we tentatively highlight several genes as possible susceptibility factor candidates involved in this peculiar phenotype.</p> <p>Conclusions</p> <p>The CNVs contained in the HLA locus region in patients with the novel phenotype of CCSVI/VM and MS were mapped in detail, demonstrating a significant correlation between the number of known CNVs found in the HLA region and the number of CCSVI-VMs identified in patients. Pathway analysis revealed common routes of interaction of several of the genes involved in angiogenesis and immunity contained within this region. Despite the small sample size in this pilot study, it does suggest that the number of multiple polymorphic CNVs in the HLA locus deserves further study, owing to their possible involvement in susceptibility to this novel MS/VM plus phenotype, and perhaps even other types of the disease.</p
The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland
The extent of population structure within Ireland is largely unknown, as is the impact of historical migrations. Here we illustrate fine-scale genetic structure across Ireland that follows geographic boundaries and present evidence of admixture events into Ireland. Utilising the ‘Irish DNA Atlas’, a cohort (n = 194) of Irish individuals with four generations of ancestry linked to specific regions in Ireland, in combination with 2,039 individuals from the Peoples of the British Isles dataset, we show that the Irish population can be divided in 10 distinct geographically stratified genetic clusters; seven of ‘Gaelic’ Irish ancestry, and three of shared Irish-British ancestry. In addition we observe a major genetic barrier to the north of Ireland in Ulster. Using a reference of 6,760 European individuals and two ancient Irish genomes, we demonstrate high levels of North-West French-like and West Norwegian-like ancestry within Ireland. We show that that our ‘Gaelic’ Irish clusters present homogenous levels of ancient Irish ancestries. We additionally detect admixture events that provide evidence of Norse-Viking gene flow into Ireland, and reflect the Ulster Plantations. Our work informs both on Irish history, as well as the study of Mendelian and complex disease genetics involving populations of Irish ancestry
Acute treatment with valproic acid and L-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats
This work was supported by grants from the Swedish Research
Council (MJ (K2008-66X-20776-01-4 and K2012-99X-20776-05-3)),
OH (2011-3457) and GCB (K2011-80P-21816-01-4 and K2011-80X-
21817-01-4)), Harald and Greta Jeanssons Foundation (MJ), Swedish
Association for Persons with Neurological Disabilities (MJ), ÅkeWibergs
Foundation (MJ), Åke Löwnertz Foundation (MJ), Swedish Brain Foundation
(MJ and GCB), David and Astrid Hagélen Foundation (GCB),
Swedish Society for Medical Research (GCB), Swedish Society of Medicine
(GCB), Socialstyrelsen (MJ), Karolinska Institutet funds (MJ and
GCB), Marie Curie Integration Grant, Seventh Framework Programme,
European Union (GCB, PCIG12-GA-2012-333713)), Neuropromise
LSHM-CT-2005-018637 (MZA, HL) and Theme Center for Regenerative
Medicine at Karolinska Institutet (OH)
Clinical correlates of grey matter pathology in multiple sclerosis
Traditionally, multiple sclerosis has been viewed as a disease predominantly affecting white matter. However, this view has lately been subject to numerous changes, as new evidence of anatomical and histological changes as well as of molecular targets within the grey matter has arisen. This advance was driven mainly by novel imaging techniques, however, these have not yet been implemented in routine clinical practice. The changes in the grey matter are related to physical and cognitive disability seen in individuals with multiple sclerosis. Furthermore, damage to several grey matter structures can be associated with impairment of specific functions. Therefore, we conclude that grey matter damage - global and regional - has the potential to become a marker of disease activity, complementary to the currently used magnetic resonance markers (global brain atrophy and T2 hyperintense lesions). Furthermore, it may improve the prediction of the future disease course and response to therapy in individual patients and may also become a reliable additional surrogate marker of treatment effect
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects
Janna Saarela on työryhmien jäsen.Peer reviewe
- …